Tumour necrosis factor gene polymorphisms as severity markers in rheumatoid arthritis

被引：46
|
作者：
Verweij, CL [1 ]
机构：
[1] Leiden Univ, Ctr Med, Dept Rheumatol C4R, NL-2300 RC Leiden, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 1999年 / 58卷
关键词：
D O I：
10.1136/ard.58.2008.i20
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：20 / 26
页数：7
相关论文
共 50 条
  • [41] Drugs that block tumour necrosis factor: Experience in patients with rheumatoid arthritis
    Moreland, LW
    [J]. PHARMACOECONOMICS, 2004, 22 (02) : 39 - 53
  • [42] Tumour necrosis factor inhibitors: risks and benefits in patients with rheumatoid arthritis
    Roberts, L
    McColl, GJ
    [J]. INTERNAL MEDICINE JOURNAL, 2004, 34 (12) : 687 - 693
  • [43] The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis
    Askling, Johan
    Dixon, Will
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2008, 20 (02) : 138 - 144
  • [44] Drugs that block tumour necrosis factor: Experience in patients with rheumatoid arthritis
    Larry W. Moreland
    [J]. PharmacoEconomics, 2004, 22 : 39 - 53
  • [45] Tumour necrosis factor alpha inhibitors for the treatment of adult rheumatoid arthritis
    McColl, G.
    [J]. AUSTRALIAN PRESCRIBER, 2005, 28 (01) : 6 - 6
  • [46] EFFICACY AND SAFETY OF TUMOUR NECROSIS FACTOR ALPHA INHIBITORS IN RHEUMATOID ARTHRITIS
    Baraza Cristina, Gomez
    Francisco Javier, Manero Ruiz
    Espasol Angela, Pecondon
    Mendoza Mercedes, Arenere
    Orbis Iciar, Casiamares
    Maria Jose, Rabanaque Hernandez
    [J]. ATENCION FARMACEUTICA, 2013, 15 (03): : 150 - 157
  • [47] No association of polymorphisms in the tumor necrosis factor receptor I and receptor II genes with disease severity in rheumatoid arthritis
    Glossop, JR
    Nixon, NB
    Dawes, PT
    Hassell, AB
    Mattey, DL
    [J]. JOURNAL OF RHEUMATOLOGY, 2003, 30 (07) : 1406 - 1409
  • [48] Tumour Necrosis Factor a Antagonists in the Treatment of Rheumatoid Arthritis: An Immunological Perspective
    Meroni, Pier-Luigi
    Valesini, Guido
    [J]. BIODRUGS, 2014, 28 : S5 - S13
  • [49] Tumour necrosis factor a −308 promoter polymorphism in patients with rheumatoid arthritis
    Zahra Rezaieyazdi
    Jalil Tavakol Afshari
    Mahnaz Sandooghi
    Farnaz Mohajer
    [J]. Rheumatology International, 2007, 28 : 189 - 191
  • [50] Tumour necrosis factor inhibitors and risk of serious infection in rheumatoid arthritis
    Katikireddi, Veera S.
    Whittle, Samuel L.
    Hill, Catherine L.
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2010, 13 (01) : 12 - 26
12345